Christopher Cannon Discusses Safe Discontinuation of Anticoagulation After AFib Ablation in a New Study
Christopher Cannon, Cardiologist at Brigham and Women’s Hospital, Editor-in-Chief of Harvard Heart Letter, posted on LinkedIn:
”In patients s/p AFib ablation who maintain sinus rhythm for more than a year (with good patch monitor documentation), stopping anticoagulation appeared safe.
I (and many of my patients) have been waiting for this trial for a long time – a question that comes up so often.
If stopping, will of course need to maintain vigilance for any late recurrence – then anticoagulation will be needed.
Good discussion and comments here noting caution. It is just one study of 800 patients.
Use of ILR is a terrific way to keep immediate look for recurrences, or Apple Watch could also work.
It also makes sense to incorporate CHAD2-Vasc score in the decision, where if it is low could feel safer stopping but if high, lean more toward current practice of continuing.”
Read the full article here.
Title: Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation
Authors: Daehoon Kim, Jaemin Shim, Eue-Keun Choi, Il-Young Oh, Jun Kim, Young Soo Lee, Junbeom Park, Jum-Suk Ko, Kyoung-Min Park, Jung-Hoon Sung, Hyung Wook Park, Hyung-Seob Park, Jong-Youn Kim, Ki-Woon Kang, Dongmin Kim, Jin-Kyu Park, Dae-Hyeok Kim, Jin-Bae Kim, Hee Tae Yu, Tae-Hoon Kim, Jae-Sun Uhm, Hui-Nam Pak, Boyoung Joung
Stay updated with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals